Senores Pharmaceuticals Ltd.

NSE: SENORES | BSE: 544319 | ISIN: INE0RB801010 | Industry: Pharmaceuticals
|
523.8500 3.70 (0.71%)
NSE Jun 23, 2025 15:31 PM
Volume: 104.0K
 

523.85
0.71%
KRChoksey
Senores Pharmaceuticals focuses on generic drugs and specialty medications across various therapeutic areas, including cardiovascular, diabetes, gastroenterology, and critical care injectables. The company manufactures products at its FDA-approved facilities, with a significant presence in regulated markets like the US, UK, and Canada.
Number of FII/FPI investors decreased from 51 to 41 in Mar 2025 qtr
More from Senores Pharmaceuticals Ltd.
Recommended